Back to WeAcuRe

Email Consent Boundary

Email can invite early users back when study products are ready, but only after clear consent, an unsubscribe path, and a documented provider boundary are in place.

Current status

EmailNot collected

The current early access form is disabled and does not submit an email address.

PurposeNotices only

Future messages should stay limited to early access, product readiness, and study updates.

SMSLater option

SMS stays separate and requires its own explicit consent before use.

Before email collection is enabled

First email fields

RequiredEmail and consent

Collect email, explicit consent, source, and date in the provider record.

PreferenceProduct, market, language

Collect product interest, market, and language only to route readiness updates.

BlockedNo birth data

Do not collect birth date, birth time, chart output, or private study notes in the email form.

Consent wording

The first live form should use a clear checkbox such as: I agree to receive WeAcuRe early access and product readiness updates by email. Each message should include unsubscribe wording, and support must process deletion requests.

Unsubscribe and deletion path

Reactivation boundary

Future reactivation messages should be sparse, product-related, and easy to leave. They should not include chart details, private birth data, or personal outcome claims.

Reactivation cadence

Reactivation record

Related pages

Review Early Access, Email Reactivation Runbook, Payment Readiness, Provider Readiness, Privacy Boundary, Data Request Boundary, Birth Data Privacy, and Support Readiness, and Contact.